openPR Logo
Press release

Next-Generation Biomanufacturing Market - Know the Untapped Revenue Growth Opportunities

04-03-2024 08:29 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: InsightAce Analytic Pvt.Ltd

/ PR Agency: InsightAce Analytic Pvt.Ltd
Next-Generation Biomanufacturing Market - Know the Untapped

Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Next-Generation Biomanufacturing Market- by Medical Applications (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins and Other Applications), Products (Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products and Downstream Biomanufacturing Products), Workflow (Upstream

Biomanufacturing and Downstream Biomanufacturing), End-Users (Biopharmaceutical Companies, CMOs (Contract manufacturing organizations)/CDMOs (Contract Development and Manufacturing Organization) and Research Institutions), Trends, Industry Competition Analysis, Revenue and Forecast To 2024-2030."

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1261

Insight Analytics estimated the global market for next-generation biomanufacturing to be worth US$ 19.85 billion in 2021. With a CAGR of 9.3% from 2022 to 2030, it is anticipated to reach US$ 43.16 billion by 2030. The next-generation biomanufacturing market, which uses biomanufacturing as the primary method for studying and creating biological-based items, is shown in the explosive rise of the biopharmaceutical business. Advanced technologies like augmented reality, machine learning, and artificial intelligence are used in next-generation biomanufacturing processes.

When these technologies are used compared to the first-generation method, the results are flawless, efficient, and of superior quality. The industry is anticipated to grow significantly due to several factors, including the availability of well-established healthcare infrastructures, the development of more efficient next-generation bioprocessing units, the growing influence of the government, the high prevalence of chronic and genetic diseases, the ageing population, and the availability of cutting-edge medical technologies. The development of drugs and materials requires complex procedures and sophisticated equipment.

To overcome these obstacles, biopharmaceutical companies employ cutting-edge biomanufacturing techniques to improve production quality and efficiency. As a result, it is projected that the production of next-generation biomanufacturing products will increase in the following years. Conversely, during the projected term, market adoption may be constrained by elements, including the need for more individuals to possess the required skills and the intricacy of the processes. Because of its robust infrastructure for biological research, well-represented major biopharmaceutical enterprises, and increased usage of novel technologies, North America is expected to contribute to the Next-Generation Biomanufacturing market over time.

In addition, the growing use of modern technologies and rising patient and consumer populations in countries like China and India will likely drive considerable growth in the Europe Next-Generation Biomanufacturing market during the forecast year. Applikon Biotechnology BV (Netherlands), bbi-biotech GmbH (Germany), Danaher Corporation (US), Meissner Filtration Products, Inc. (US), Merck KGaA (Germany), PBS Biotech, Inc. (US), Pierre Guérin (France), Sartorius AG (Germany), Shanghai Bailun Biotechnology Co. Ltd. (China), Solaris Biotechnology Srl. (Italy), Thermo Fisher Scientific Inc. (US), ZETA GmbH (Austria), and others are significant market players in Next-Generation Biomanufacturing.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1261

Recent collaborations and agreements in the market:

In August 2021, PBS Biotech (US) raised its most significant round of funding from BroadOak Capital Partners to develop its product offerings and capabilities. The funds will be utilized to increase PBS's product offerings and capabilities and address the demand for cell therapies.
In February 2021, Merck (Germany) collaborated with Alteogen, Inc. (South Korea), which provides late-stage CDMO services via Merck's BioReliance end-to-end solutions. Alteogen chose Merck to develop and manufacture recombinant biologics for developing and clinical testing next-generation monoclonal antibody medicines.

Market Segments

Global Next-Generation Biomanufacturing Market, by Medical Applications, 2022-2030 (Value US$ Mn)

• Monoclonal Antibodies
• Hormones
• Vaccines
• Recombinant Proteins
• Other Applications

Global Next-Generation Biomanufacturing Market, by Products, 2022-2030 (Value US$ Mn)

• Continuous Upstream Biomanufacturing Products
• Single-Use Upstream Biomanufacturing Products
• Downstream Biomanufacturing Products

Global Next-Generation Biomanufacturing Market, by Workflow, 2022-2030 (Value US$ Mn)

• Upstream Biomanufacturing
• Downstream Biomanufacturing

Global Next-Generation Biomanufacturing Market, by End-Users, 2022-2030 (Value US$ Mn)

• Biopharmaceutical Companies
• CMOs (Contract manufacturing organizations)/CDMOs (Contract Development and Manufacturing organizations)
• Research Institutions

Global Next-Generation Biomanufacturing Market, by Region, 2022-2030 (Value US$ Mn)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• U.S.
• Canada

Europe Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)

• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Next-Generation Biomanufacturing market
 To receive an industry overview and future trends in the Next-Generation Biomanufacturing market
 To analyze the Next-Generation Biomanufacturing market drivers and challenges
 To get information on the Next-Generation Biomanufacturing market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Next-Generation Biomanufacturing market industry

For More Information @ https://www.insightaceanalytic.com/customisation/1261

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next-Generation Biomanufacturing Market - Know the Untapped Revenue Growth Opportunities here

News-ID: 3451147 • Views:

More Releases from InsightAce Analytic Pvt.Ltd

Biosimilar Monoclonal Antibodies Market Latest Report with Forecast to 2031
Biosimilar Monoclonal Antibodies Market Latest Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biosimilar Monoclonal Antibodies Market- by Product (Infliximab, Trastuzumab, Rituximab, Adalimumab, Bevacizumab, Cetuximab, Ranibizumab, Denosumab, Eculizumab and Other Pipeline Products), Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders and Other Indication), Trends, Industry Competition Analysis, Revenue and Forecast To 2024- 2030." Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1218 InsightAce Analytic's most recent study
Cell and Gene Therapy Supply Chain/Logistics Market Reviews Analysis Report 2024
Cell and Gene Therapy Supply Chain/Logistics Market Reviews Analysis Report 2024
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Cell and Gene Therapy Supply Chain/Logistics Market (By Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification and treatment follow-up), By Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system), By Mode of Deployment
Preclinical Oncology Models Market - Recent Innovations and Upcoming Trends Analysis
Preclinical Oncology Models Market - Recent Innovations and Upcoming Trends Anal …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Preclinical Oncology Models Market- by Product (Patient-Derived Xenograft Models (PDX), Cell Line Derived Xenograft Models, Syngeneic Models, Genetically engineered mouse models (GEMMs), Orthotopic Models, Custom Xenograft and Syngeneic Model and Others), Application (Neuroblastoma, Prostate Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Fibrosarcoma, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer and Others),
2D Materials Market 2024-2031 | Exclusive Study Report
2D Materials Market 2024-2031 | Exclusive Study Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global 2D Materials Market Size, Share & Trends Analysis Report By Material (Graphene, Black Phosphorous, Transition Metal Dichalcogenides, Mxenes, Hexagonal Boron Nitride), And End Users (Composite And Coating, Energy Storage Devices, Electronics, Semiconductors, Pharmaceuticals, Automobiles )- Market Outlook And Industry Analysis 2031" The 2D Materials market will reach over USD 36.27 billion by 2024-2031, exhibiting

All 5 Releases


More Releases for Biomanufacturing

Next-Generation Biomanufacturing Market Growth Analysis Report 2021-2027
Next-generation biomanufacturing technologies enable the synthesis of stereospecific products that can easily tune these synthetic reactions. These procedures can also be cost-effective and ecologically beneficial. This white paper describes a new technique that increases yield and product properties while avoiding the drawbacks of extensive extraction and purification operations. “Next-Generation Biomanufacturing Market is growing at a 15% CAGR during the forecast period 2020-2026”. Research Informatics announces the release of the Next-Generation Biomanufacturing
Digital Biomanufacturing Market- Trends, Share, Size, Manufacturers Analysis and …
The Global Digital Biomanufacturing Industry: 2020 Market Report is a professional and in-depth study on the current state of the Digital Biomanufacturing Market. Complete report on Digital Biomanufacturing market spread across 94 pages, profiling 10 companies and supported with tables and figures is now available at https://www.deepresearchreports.com/contacts/inquiry.php?name=1229141 The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Digital Biomanufacturing market analysis is
Global Contract Biomanufacturing Services Market Size, Status, Demand, Overview …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Contract Biomanufacturing Services Market Size, Status and Forecast 2025” provides an in-depth analysis of the Biomanufacturing Services with the forecast of market size and growth. The analysis includes addressable market, market by volume, and market share by business type and by segment (external and in-house).The research study examines the Biomanufacturing
Flexible Biomanufacturing Platform Market: Size and Segment Forecasts2016 – 20 …
Flexible Biomanufacturing Platform Market: Overview Traditional approaches to GMP facility design often tend to focus on the physical attributes or the process scales as a function of single-product throughput. This approach neglects the foundation of flexibility, especially in the process of balancing the quality of product and manufacturing costs. Hence, the design and implementation of flexible production processes is being established globally to meet the industry’s emerging economic and production capacity
Flexible Biomanufacturing Platform Market is Expected to Witness Highest Growth …
Traditional approaches to GMP facility design often tend to focus on the physical attributes or the process scales as a function of single-product throughput. This approach neglects the foundation of flexibility, especially in the process of balancing the quality of product and manufacturing costs. Hence, the design and implementation of flexible production processes is being established globally to meet the industry's emerging economic and production capacity requirements. The flexible biomanufacturing
Flexible Biomanufacturing Platform Market 2016 : Demand, Insights, Analysis, Opp …
Traditional approaches to GMP facility design often tend to focus on the physical attributes or the process scales as a function of single-product throughput. This approach neglects the foundation of flexibility, especially in the process of balancing the quality of product and manufacturing costs. Hence, the design and implementation of flexible production processes is being established globally to meet the industry's emerging economic and production capacity requirements. The flexible biomanufacturing